911112-05-5

Basic information

• Product Name: 5-Iodo-3-(trifluoromethyl)-2-pyridinamine
• Synonyms: 5-Iodo-3-(trifluoromethyl)-2-pyridinamine;5-Iodo-3-trifluoroMethyl-pyridin-2-ylaMine;5-iodo-3-(trifluoroMethyl)pyridin-2-aMine
• CAS NO: 911112-05-5
• Molecular Formula: C6H4F3IN2
• Molecular Weight: 288
• Mol File: 911112-05-5.mol

Chemical Properties

• Boiling Point: 279℃
• Flash Point: 123℃
• Appearance: /
• Density: 2.049
• Storage Temp.: 2-8°C(protect from light)
• PKA: 2.19±0.49(Predicted)
• CAS DataBase Reference: 5-Iodo-3-(trifluoromethyl)-2-pyridinamine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Iodo-3-(trifluoromethyl)-2-pyridinamine(911112-05-5)
• EPA Substance Registry System: 5-Iodo-3-(trifluoromethyl)-2-pyridinamine(911112-05-5)

Safety Data

• Hazardous Substances Data: 911112-05-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
5-Iodo-3-(trifluoromethyl)-2-pyridinamine is used as a building block for the synthesis of complex organic molecules due to its unique combination of functional groups and reactivity.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5-Iodo-3-(trifluoromethyl)-2-pyridinamine is utilized as a key intermediate for the development of pharmaceutical drugs, leveraging its structural features to enhance drug properties such as potency, selectivity, and pharmacokinetics.
Used in Agrochemicals:
5-Iodo-3-(trifluoromethyl)-2-pyridinamine is employed as a component in the synthesis of agrochemicals, contributing to the development of effective and targeted pest control agents.
Used in Fine Chemicals Production:
5-Iodo-3-(trifluoromethyl)-2-pyridinamine is also used in the production of fine chemicals, where its specific properties are harnessed to create high-quality specialty chemicals for various applications.
Used in Chemical Reactions and Processes:
Due to its high reactivity and stability, 5-Iodo-3-(trifluoromethyl)-2-pyridinamine is an important component in a variety of chemical reactions and processes, facilitating the creation of new compounds and materials with desired properties.

Upstream product

• 79456-34-1 5-bromo-3-(trifluoromethyl)pyridin-2-amine 
• 183610-70-0 2-amino-3-trifluoromethylpyridine 

Relevant articles and documents

BENZAMIDE DERIVATIVE

The present invention relates to benzamide derivatives represented by formula (I) or pharmaceutically acceptable salts thereof.

5-ALKYNYL-PYRIMIDINES

The present invention encompasses compounds of general formula (1) wherein R1 to R4 R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.

5-ALKYNYL PYRIMIDINES AND THEIR USE AS KINASE INHIBITORS

The present invention encompasses compounds of general formula (1) wherein R1 to R4 R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.

5-ALKYNYL-PYRIMIDINES

The present invention encompasses compounds of general Formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use th

5-ALKYNYL-PYRIDINES

The present invention encompasses compounds of general Formula (I), wherein R1 to R4, m and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.

PIPERIDINYL CYCLIC AMIDO ANTIVIRAL AGENTS

Provided are compounds of Formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).

Acetylenyl-pyrazolo-pyrimidine derivatives

The present invention relates to compounds of formula (I): wherein R1 to R3, A, M, L, E, G, and J are as defined in the description and claims. The invention also relates to a process for the manufacture of such compounds, pharmaceutical compositions containing them, and methods for treating CNS disorders.